{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:58:47Z","timestamp":1790373527035,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021821","name":"Oncode Institute","doi-asserted-by":"publisher","award":["NGFOP2201"],"award-info":[{"award-number":["NGFOP2201"]}],"id":[{"id":"10.13039\/501100021821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmorwd.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Real World Data and Digital Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.esmorw.2026.100778","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:58:50Z","timestamp":1790099930000},"page":"100778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-4584","authenticated-orcid":false,"given":"S.J.F.","family":"Hermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-1663","authenticated-orcid":false,"given":"J.","family":"Versluis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Langhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-7427","authenticated-orcid":false,"given":"E.D.","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Huls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chitu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Westerweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Fiets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0771-5231","authenticated-orcid":false,"given":"L.W.","family":"Tick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.E.","family":"Herbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-4446","authenticated-orcid":false,"given":"M.F.","family":"Corsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Breems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.S.","family":"Nijhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cruijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Davidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.G.","family":"van der Hem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Baboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-2346","authenticated-orcid":false,"given":"E.F.M.","family":"Posthuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7145-2415","authenticated-orcid":false,"given":"K.","family":"Schade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Berkx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-6716","authenticated-orcid":false,"given":"A.G.","family":"Dinmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Huijgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.esmorw.2026.100778_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cpt.2914","article-title":"Effectively leveraging RWD for external controls: a systematic literature review of regulatory and HTA decisions","volume":"114","author":"Sola-Morales","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.esmorw.2026.100778_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028133","article-title":"Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013-2017","volume":"9","author":"Brown","year":"2019","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.esmorw.2026.100778_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/pds.4932","article-title":"Trial designs using real-world data: the changing landscape of the regulatory approval process","volume":"29","author":"Baumfeld Andre","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100778_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cpt.1426","article-title":"Real-world data for regulatory decision making: challenges and possible solutions for Europe","volume":"106","author":"Cave","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.esmorw.2026.100778_bib5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/cpt.3218","article-title":"Real-world evidence to inform regulatory decision making: a scoping review","volume":"115","author":"Jansen","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.esmorw.2026.100778_bib6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jamaoncol.2024.3466","article-title":"Externally controlled studies using real-world data in patients with hematological cancers: a systematic review","volume":"10","author":"Hermans","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmorw.2026.100778_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113056","article-title":"Real-time data in cancer registries: validation of an automated data extraction system","volume":"28","author":"Langhout","year":"2025","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100778_bib8","first-page":"361","article-title":"Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome","volume":"104","author":"Huls","year":"2025","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.esmorw.2026.100778_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100778_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.esmorw.2026.100778_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100778_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100778_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.esmorw.2026.100778_bib14","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.esmorw.2026.100778_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100778_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.esmorw.2026.100778_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjh.20185","article-title":"Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients","volume":"208","author":"Hermans","year":"2026","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100778_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/EDE.0000000000001267","article-title":"Single-arm trials with historical controls: study designs to avoid time-related biases","volume":"32","author":"Suissa","year":"2021","journal-title":"Epidemiology"},{"issue":"19","key":"10.1016\/j.esmorw.2026.100778_bib19","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1182\/bloodadvances.2022009167","article-title":"Enriching single-arm clinical trials with external controls: possibilities and pitfalls","volume":"7","author":"Lambert","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.esmorw.2026.100778_bib20","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1002\/onco.13696","article-title":"Implementing historical controls in oncology trials","volume":"26","author":"Collignon","year":"2021","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100778_bib21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2006.06476.x","article-title":"The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia","volume":"136","author":"Giles","year":"2007","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.esmorw.2026.100778_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2012-03-414573","article-title":"Validation of the hematopoietic cell transplantation-specific comorbidity index: a prospective, multicenter GITMO study","volume":"120","author":"Raimondi","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100778_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.leukres.2011.11.021","article-title":"The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients","volume":"36","author":"Savic","year":"2012","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.esmorw.2026.100778_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3324\/haematol.2012.067892","article-title":"Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome","volume":"98","author":"Deschler","year":"2013","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.esmorw.2026.100778_bib25","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","article-title":"Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia","volume":"121","author":"Klepin","year":"2013","journal-title":"Blood"},{"issue":"35","key":"10.1016\/j.esmorw.2026.100778_bib26","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1200\/JCO.20.01392","article-title":"Accuracy of SIE\/SIES\/GITMO consensus criteria for unfitness to predict early mortality after intensive chemotherapy in adults with AML or other high-grade myeloid neoplasm","volume":"38","author":"Palmieri","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.esmorw.2026.100778_bib27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s11912-022-01299-9","article-title":"Older patients with acute myeloid leukemia deserve individualized treatment","volume":"24","author":"De Leeuw","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.esmorw.2026.100778_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101224","article-title":"Breaking down frailty: assessing vulnerability in acute myeloid leukemia","volume":"68","author":"Williams","year":"2024","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100778_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s43441-020-00193-5","article-title":"Bridging the gap between RCTs and RWE through endpoint selection","volume":"55","author":"LoCasale","year":"2021","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.esmorw.2026.100778_bib30","article-title":"Semiautomated pipeline to quantify tumor evolution from real-world positron emission tomography\/computed tomography imaging","volume":"7","author":"Abler","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"issue":"2","key":"10.1016\/j.esmorw.2026.100778_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/jpm11020065","article-title":"GENERATOR Breast DataMart\u2014the novel breast cancer data discovery system for research and monitoring: preliminary results and future perspectives","volume":"11","author":"Marazzi","year":"2021","journal-title":"J Pers Med"},{"issue":"21","key":"10.1016\/j.esmorw.2026.100778_bib32","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2217\/fon-2019-0150","article-title":"Extracting data from a chemotherapy prescription platform for real-world oncology research in the UK: a pilot study","volume":"15","author":"McDonald","year":"2019","journal-title":"Future Oncol"},{"issue":"10","key":"10.1016\/j.esmorw.2026.100778_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12869","article-title":"Feasibility of using real-world data to replicate clinical trial evidence","volume":"2","author":"Bartlett","year":"2019","journal-title":"JAMA Netw Open"}],"container-title":["ESMO Real World Data and Digital Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820126000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820126000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:04Z","timestamp":1790370184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949820126000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S2949820126000974"],"URL":"https:\/\/doi.org\/10.1016\/j.esmorw.2026.100778","relation":{},"ISSN":["2949-8201"],"issn-type":[{"value":"2949-8201","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"ESMO Real World Data and Digital Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmorw.2026.100778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100778"}}